These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32152150)

  • 1. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.
    Evrard YA; Srivastava A; Randjelovic J; Doroshow JH; Dean DA; Morris JS; Chuang JH;
    Cancer Res; 2020 Jun; 80(11):2286-2297. PubMed ID: 32152150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
    Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
    Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.
    Kamili A; Gifford AJ; Li N; Mayoh C; Chow SO; Failes TW; Eden GL; Cadiz R; Xie J; Lukeis RE; Norris MD; Haber M; McCowage GB; Arndt GM; Trahair TN; Fletcher JI
    Br J Cancer; 2020 Mar; 122(5):680-691. PubMed ID: 31919402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery.
    Koc S; Lloyd MW; Grover JW; Xiao N; Seepo S; Subramanian SL; Ray M; Frech C; DiGiovanna J; Webster P; Neuhauser S; Srivastava A; Woo XY; Sanderson BJ; White B; Lott P; Dobrolecki LE; Dowst H; ; Evrard YA; Wallace TA; Moscow JA; Doroshow JH; Mitsiades N; Kaochar S; Pan CX; Chen MS; Carvajal-Carmona L; Welm AL; Welm BE; Lewis MT; Govindan R; Ding L; Li S; Herlyn M; Davies MA; Roth J; Meric-Bernstam F; Robinson PN; Bult CJ; Davis-Dusenbery B; Dean DA; Chuang JH
    NAR Cancer; 2022 Jun; 4(2):zcac014. PubMed ID: 35475145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis.
    Wulf-Goldenberg A; Hoffmann J; Becker M; Brzezicha B; Walther W
    Methods Mol Biol; 2021; 2294():43-58. PubMed ID: 33742393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
    Fuchs V; Sobarzo A; Msamra M; Kezerle Y; Linde L; Sevillya G; Anoze A; Refaely Y; Cohen AY; Melamed I; Azriel A; Shoukrun R; Raviv Y; Porgador A; Peled N; Roisman LC
    Clin Transl Oncol; 2024 Sep; 26(9):2227-2239. PubMed ID: 38553659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived xenograft models for personalized medicine in colorectal cancer.
    Xie J; Lin Y
    Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
    Shi J; Li Y; Jia R; Fan X
    Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
    Izumchenko E; Paz K; Ciznadija D; Sloma I; Katz A; Vasquez-Dunddel D; Ben-Zvi I; Stebbing J; McGuire W; Harris W; Maki R; Gaya A; Bedi A; Zacharoulis S; Ravi R; Wexler LH; Hoque MO; Rodriguez-Galindo C; Pass H; Peled N; Davies A; Morris R; Hidalgo M; Sidransky D
    Ann Oncol; 2017 Oct; 28(10):2595-2605. PubMed ID: 28945830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
    Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R
    Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
    Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
    Cells; 2019 May; 8(5):. PubMed ID: 31126020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
    Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P
    Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Application of Genetic Ancestry Reconstruction Methods to Study Diversity of Patient-Derived Models in the NCI PDXNet Consortium.
    Lott PC; Chiu K; Quino JE; Vang AP; Lloyd MW; Srivastava A; Chuang JH; ; Carvajal-Carmona LG
    Cancer Res Commun; 2024 Aug; 4(8):2147-2152. PubMed ID: 39056190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
    Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
    Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived xenografts as in vivo models for research in urological malignancies.
    Inoue T; Terada N; Kobayashi T; Ogawa O
    Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Of Mice and Melanoma: PDX System for Modeling Personalized Medicine.
    Hartsough EJ; Aplin AE
    Clin Cancer Res; 2016 Apr; 22(7):1550-2. PubMed ID: 26842234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.